Evidence map›Paper›PMID 19759905›Full record

ArticlePloS one2009

Evaluation and validation of a real-time PCR assay for detection and quantitation of human adenovirus 14 from clinical samples.

David Metzgar, Greg Skochko, Carl Gibbins, Nolan Hudson, Lisa Lott, Morris S Jones

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Emerging respiratory viruses other than influenza.Clinics in laboratory medicine · 2014
    Review
  4. Article
  5. Genotyping of clinically relevant human adenoviruses by array-in-well hybridization assay.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2013
    Article
  6. Article
  7. A comparison of viral fitness and virulence between emergent adenovirus 14p1 and prototype adenovirus 14p strains.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2012
    Article
  8. Article
  9. Article
  10. The role of adenovirus in respiratory tract infections.Current infectious disease reports · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

David MetzgarDepartment of Respiratory Disease Research, Naval Health Research Center, San Diego, CA, USA.
Greg Skochko
Carl Gibbins
Nolan Hudson
Lisa Lott
Morris S Jones
David Grant USAF Medical Center · USJoint Base San Antonio · USUnited States Air Force · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In 2007, the Centers for Disease Control and Prevention (CDC) reported that Human adenovirus type 14 (HAdV-14) infected 106 military personnel and was responsible for the death of one U.S. soldier at Lackland Air Force Base in Texas. Identification of the responsible adenovirus, which had not previously been seen in North America and for which rapid diagnostic tools were unavailable, required retrospective analysis at reference laboratories. Initial quarantine measures were also reliant on relatively slow traditional PCR analysis at other locations. To address this problem, we developed a real-time PCR assay that detects a 225 base pair sequence in the HAdV-14a hexon gene. Fifty-one oropharyngeal swab specimens from the Naval Health Research Center, San Diego, CA and Advanced Diagnostic Laboratory, Lackland AFB, TX were used to validate the new assay. The described assay detected eight of eight and 19 of 19 confirmed HAdV-14a clinical isolates in two separate cohorts from respiratory disease outbreaks. The real-time PCR assay had a wide dynamic range, detecting from 10(2) to 10(7) copies of genomic DNA per reaction. The assay did not cross-react with other adenoviruses, influenza, respiratory syncytial virus, or common respiratory tract bacteria. The described assay is easy to use, sensitive and specific for HAdV-14a in clinical throat swab specimens, and very rapid since turnaround time is less than four hours to obtain an answer.

Indexed as

Adenoviruses, HumanAdenovirus Infections, HumanBase SequenceCohort StudiesDisease OutbreaksHumansMolecular Sequence DataReproducibility of ResultsRespiratory Tract DiseasesReverse Transcriptase Polymerase Chain ReactionRNA, ViralSensitivity and SpecificitySequence Homology, Nucleic AcidTime FactorsRNA, Viral

Identifiers

PMID19759905
PMCPMC2738968
OpenAlexW2083950614

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.